Efficacy of Lithium Against Chemotherapy Induced Neutropenia in Breast Cancer Patients

• Status: Recruiting
• Trial end date: 2022-06-01
• Target enrollment: 0
• Participant gender: All

Summary

Using Lithium Carbonate to decrease incidence of neutropenia caused by using chemotherapy regimen in breast cancer patients.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Al-Azhar University
• Treatments: Lithium Carbonate

Criteria

Inclusion Criteria:

1. All patients presented with breast cancer documented by pathological reports stage I, II and III.

Exclusion Criteria:

1. Patients receiving cardiac medication such as diuretics.

2. Patients on sodium-restricted diet (to avoid lithium toxicity).

3. Stage IV with expected short overall survival.

4. Patients with blood or bone marrow cancer (to prevent interference).

5. Patients with hepatic and renal impairment.

6. Patient with untreated hypothyroidism.

7. Pregnant and breast feeding patients.